You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Expert Perspectives in the Treatment Success of Tardive Dyskinesia

  • Authors: Kapil Sethi, MD; Karen Anderson, MD; Cynthia Comella, MD
  • CME / ABIM MOC Released: 10/22/2020; Reviewed and Renewed: 10/22/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 10/22/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for psychiatrists, neurologists, and primary care physicians.

The goal of this activity is to inform clinicians regarding the assessment and treatment of patients with tardive dyskinesia, including the use of vesicular monoamine transporter-2 (VMAT2) inhibitors.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • The development of personalized treatment regimens for patients experiencing tardive dyskinesia
    • The assessment of the effectiveness of therapeutic interventions to manage tardive dyskinesia


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Kapil Sethi, MD

    Emeritus Professor
    Neurology
    Medical College of Georgia
    Augusta, Georgia

    Disclosures

    Disclosure: Kapil Sethi, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Neurocrine

Panelists

  • Karen Anderson, MD

    Professor
    Neurology and Psychiatry
    Georgetown University School of Medicine
    Washington, DC

    Disclosures

    Disclosure: Karen Anderson, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Azevan; Lundbeck; Novartis; Teva

  • Cynthia Comella, MD

    Professor
    Neurosurgery and Neurological Sciences
    Rush Medical College
    Chicago, Illinois

    Disclosures

    Disclosure: Cynthia Comella, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Acadia; Acorda; Aeon Pharmaceutical; Ipsen Pharmaceutical; Jazz; Lundbeck; Merz; Neurocrine; Revance

Editors

  • Lisa Brauer, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Lisa Brauer, PhD, has disclosed no relevant financial relationships.

  • Heather Lewin, MAT

    Associate Director, Medscape, LLC

    Disclosures

    Disclosure: Heather Lewin, MAT, has disclosed no relevant financial relationships.

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Expert Perspectives in the Treatment Success of Tardive Dyskinesia

Authors: Kapil Sethi, MD; Karen Anderson, MD; Cynthia Comella, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 10/22/2020; Reviewed and Renewed: 10/22/2021

Valid for credit through: 10/22/2022

processing....

Educational Impact Challenge

The goal of this activity is to inform clinicians regarding the assessment and treatment of patients with tardive dyskinesia, including the use of VMAT2 inhibitors.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print